Trials / Conditions / Molluscum Contagiosum

Molluscum Contagiosum

21 registered clinical trials studyying Molluscum Contagiosum.

Status	Trial	Sponsor	Phase
Terminated	Cold Atmospheric Plasma Device Extension Study NCT05937672	Medical University of South Carolina	Phase 3
Completed	Study of a Cohort of Children With Molluscum Contagiosum (MC) Treated With a 5% Solution of Potassium Hydroxid NCT05680181	Laboratoire Dermatologique ACM	—
Completed	Comparative Efficacy of 10% Potassium Hydroxide Solution Versus Cryotherapy in Molluscum Contagiosum NCT05897112	Combined Military Hospital Abbottabad	Phase 1
Withdrawn	MC RCT - BPO vs Adapalene NCT05536882	University of Oklahoma	Phase 3
Completed	Comparison of 5% Potassium Hydroxide With 10% Potassium Hydroxide Solution in Treatment of Molluscum Contagios NCT05634460	Combined Military Hospital Abbottabad	Phase 1
Completed	A Phase 3 Molluscum Contagiosum Efficacy and Safety Study NCT04535531	Novan, Inc.	Phase 3
Unknown	The Effectiveness of Oral Acyclovir in the Treatment of Molluscum Contagiosum in Children NCT04476186	Dalia Mahran	N/A
Completed	A Phase 3 Efficacy & Safety of SB206 & Vehicle Gel for the Treatment of MC NCT03927703	Novan, Inc.	Phase 3
Completed	A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatm NCT03927716	Novan, Inc.	Phase 3
Completed	Cantharidin Application in Molluscum Patients-1 NCT03377790	Verrica Pharmaceuticals Inc.	Phase 3
Completed	Cantharidin Application in Molluscum Patients NCT03377803	Verrica Pharmaceuticals Inc.	Phase 3
Completed	A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum NCT03436615	Novan, Inc.	Phase 2
Withdrawn	Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients NCT03336372	Center for Clinical Studies, Texas	EARLY_Phase 1
Completed	Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum. NCT03186378	Verrica Pharmaceuticals Inc.	Phase 2
Completed	A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum NCT03077750	Veloce BioPharma LLC	Phase 2
Completed	Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo NCT02902822	Centro Studi Gised	N/A
Completed	Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum, Phase 2 NCT03017846	Steven R Cohen	Phase 2
Terminated	A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Molluscum Contag NCT02024581	ViroXis Corporation	Phase 2
Unknown	Using a Cold Atmospheric Plasma Device to Treat Skin Disorders NCT02759900	The Skin Center Dermatology Group	N/A
Completed	Safety and Efficacy Study of Topical Cantharidin for the Treatment of Molluscum Contagiosum NCT02665260	Montefiore Medical Center	Phase 2
Completed	Efficacy and Tolerance of Potassium Hydroxide (10% and 15%) in Molluscum Contagiosum NCT01348386	Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina	Phase 2 / Phase 3